Advances in the Application of Nanozymes in Joint Disease Therapy
Abstract
Nanozymes are nanoscale materials with enzyme-mimicking catalytic properties. Nanozymes can mimic the mechanism of natural enzyme molecules. By means of advanced chemical synthesis technology, the size, shape, and surface characteristics of nanozymes can be accurately regulated, and their catalytic properties can be customized according to the specific need. Nanozymes can mimic the function of natural enzymes, including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx), to scavenge reactive oxygen species (ROS). Reported findings have shown that nanozymes have the advantages of excellent stability, low cost, and adjustable catalytic activity, thereby showing great potential and broad prospects in the application of disease treatment. Herein, we reviewed the advances in the application of nanozymes in the treatment of joint diseases. The common clinical manifestations of joint diseases include joint pain, swelling, stiffness, and limited mobility. In severe cases, joint diseases may lead to joint destruction, deformity, and functional damage, entailing crippling socioeconomic burdens. ROS is a product of oxidative stress. Increased ROS in the joints can induce macrophage M1 type polarization, which in turn induces and aggravates arthritis. Therefore, the key to the treatment of joint diseases lies in ROS scavenging and increasing oxygen (O2) content. Nanozymes have demonstrated promising application potential in the treatment of joint diseases, including rheumatoid arthritis, osteoarthritis, and gouty arthritis. However, how to ensure their biosafety, reduce the toxicity, and increase enzyme activity remains the main challenge in current research. Precise control of the chemical composition, size, shape, and surface modification of nanomaterials is the main development direction for the future.
Keywords: Nanozyme, Arthritis. Reactive oxygen species, Application progress
Full Text:
PDFReferences
REN X, CHEN D, WANG Y, et al. Nanozymes-recent development and biomedical applications. J Nanobiotechnol, 2022, 20(1): 92. doi: 10.1186/s12951-022-01295-y.
SHEN X, WANG Z, GAO X J, et al. Reaction mechanisms and kinetics of nanozymes: insights from theory and computation. Adv Mater, 2024, 36(10): e2211151. doi: 10.1002/adma.202211151.
ZANDIEH M, LIU J. Nanozymes: definition, activity, and mechanisms. Adv Mater, 2024, 36(10): e2211041. doi: 10.1002/adma.202211041.
CHEN Z, YU Y, GAO Y, et al. Rational design strategies for nanozymes. ACS Nano, 2023, 17(14): 13062–13080. doi: 10.1021/acsnano.3c04378.
SONG N, YU Y, ZHANG Y, et al. Bioinspired hierarchical self-assembled nanozyme for efficient antibacterial treatment. Adv Mater, 2024, 36(10): e2210455. doi: 10.1002/adma.202210455.
NAVYATHA B, SINGH S, NARA S. AuPeroxidase nanozymes: promises and applications in biosensing. Biosens Bioelectron, 2021, 175: 112882. doi: 10.1016/j.bios.2020.112882.
YUAN R, LI Y, HAN S, et al. Fe-curcumin nanozyme-mediated reactive oxygen species scavenging and anti-inflammation for acute lung injury. ACS Cent Sci, 2022, 8(1): 10–21. doi: 10.1021/acscentsci.1c00866.
YANG L, DONG S, GAI S, et al. Deep insight of design, mechanism, and cancer theranostic strategy of nanozymes. Nanomicro Lett, 2023, 16(1): 28. doi: 10.1007/s40820-023-01224-0.
ANSARI M A, SHOAIB S, CHAUHAN W, et al. Nanozymes and carbon-dots based nanoplatforms for cancer imaging, diagnosis and therapeutics: current trends and challenges. Environ Res, 2024, 241: 117522. doi: 10. 1016/j.envres.2023.117522.
JIANG B, FANG L, WU K, et al. Ferritins as natural and artificial nanozymes for theranostics. Theranostics, 2020, 10(2): 687–706. doi: 10. 7150/thno.39827.
CHEN T, LU Y, XIONG X, et al. Hydrolytic nanozymes: preparation, properties, and applications. Adv Colloid Interface Sci, 2024, 323: 103072. doi: 10.1016/j.cis.2023.103072.
LI L, CAO S, WU Z, et al. Modulating electron transfer in vanadium-based artificial enzymes for enhanced ROS-catalysis and disinfection. Adv Mater, 2022, 34(17): e2108646. doi: 10.1002/adma.202108646.
KEUM C, HIRSCHBIEGEL C M, CHAKRABORTY S, et al. Biomimetic and bioorthogonal nanozymes for biomedical applications. Nano Converg, 2023, 10(1): 42. doi: 10.1186/s40580-023-00390-6.
TANG M, ZHANG Z, SUN T, et al. Manganese-based nanozymes: preparation, catalytic mechanisms, and biomedical applications. Adv Healthc Mater, 2022, 11(21): e2201733. doi: 10.1002/adhm.202201733.
FEDELI S, IM J, GOPALAKRISHNAN S, et al. Nanomaterial-based bioorthogonal nanozymes for biological applications. Chem Soc Rev, 2021, 50(24): 13467–13480. doi: 10.1039/d0cs00659a.
CAO S, ZHAO Z, ZHENG Y, et al. A library of ROS-catalytic metalloenzyme mimics with atomic metal centers. Adv Mater, 2022, 34(16): e2200255. doi: 10.1002/adma.202200255.
FENG Z, XIANG X, HUANG J, et al. Intelligent sonocatalytic nanoagents for energy conversion‐based therapies. Adv Funct Mater, 2023, 33(45): 2302579. doi: 10.1002/adfm.202302579.
LI Y, LIANG Q, ZHOU L, et al. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization. Acta Biomaterialia, 2022, 152: 406–424. doi: 10.1016/j.actbio.2022.08.054.
CUTOLO M, CAMPITIELLO R, GOTELLI E, et al. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis. Front Immunol, 2022, 13: 867260. doi: 10.3389/fimmu.2022.867260.
Refbacks
- There are currently no refbacks.